Global Bioglass Market Insights, Forecast to 2028

Bioglass is commonly referred to as a class of bioactive glasses specifically composed with silica (SiO2), calcium oxide (CaO), sodium oxide (Na2O), and phosphorous pentoxide (P2O5). Bioglass can repair, replace and regenerate the body tissue. Also, it forms a bond of cooperation between the organization and the used material. So it is widely used in clinical repair for orthopedic repair or dental. With the development Of the downstream industries, production of bioglass keeps increasing in recent years.
Market Analysis and Insights: Global Bioglass Market
Due to the COVID-19 pandemic, the global Bioglass market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 45S5 accounting for % of the Bioglass global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Orthopedics segment is altered to an % CAGR throughout this forecast period.
China Bioglass market size is valued at US$ million in 2021, while the US and Europe Bioglass are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bioglass landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Bioglass include Ferro, SCHOTT, Mo-Sci Corporation, Stryker, Bonalive, NovaBone, Synergy Biomedical and Dingsheng Biology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Bioglass capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Bioglass by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Bioglass Scope and Segment
Bioglass market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bioglass market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
45S5
S53P4
Others
Segment by Application
Orthopedics
Dentistry
Cosmetics and Cosmeceutical Products
Others
By Company
Ferro
SCHOTT
Mo-Sci Corporation
Stryker
Bonalive
NovaBone
Synergy Biomedical
Dingsheng Biology
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-20227820

15-Feb-2022

92
License